Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Poyhonen John, Président et Directeur Commercial. Director active across 2 companies, notably Heron Therapeutics, INC.. Cumulatively, 9 filings have been published. Activity tracked since 30 April 2021. The latest transaction was disclosed on 29 October 2021 (J). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations
POYHONEN JOHN is President & CCO at Heron Therapeutics, INC. and HERON THERAPEUTICS, INC. /DE/. He has made 9 filings in total, and across the recent sampled filings between 2021-07-15 and 2023-04-17, the stated transaction nature is option exercise.